Zafi Avnur, Ph.D.

Dr. Avnur is chief scientific officer at Quark Venture Inc. Prior to joining Quark, she was the global head of academic innovation at Roche Partnering from 2009 to 2016 where she was responsible for creating relationships with the world’s leading academic institutions and world-class innovators. Dr. Avnur has helped create nine startup companies and was named global head of neglected diseases at Roche Partnering from 2010 to 2012. Before she took on partnering roles, she worked in diagnostic and pharmaceutical research and development for nearly 20 years. She held numerous positions progressing from scientist and manager to holding global responsibilities. She oversaw the advancement of compounds from the bench into the clinic and was involved in the design and execution of early clinical studies that characterize the pharmacodynamics and clinical effects of a number of compounds. Dr. Avnur received her Ph.D. in cell biology from the Weizmann Institute and completed postdoctoral training in cancer biology at Stanford University.